7Baggers
 Price to sales forward of Sutro Biopharma, Inc. – NASDAQ:STRO  TradingView Wed, 08 Jul 2026 04:21:12 GMT
 Sutro Biopharma, Inc.(NasdaqGM: STRO) added to Russell 3000E Index  marketscreener.com Mon, 29 Jun 2026 06:41:11 GMT
 Sutro Biopharma, Inc.(NasdaqGM: STRO) added to Russell 3000E Value Benchmark  marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
 Sutro Biopharma, Inc. Actuals & Estimates (NASDAQ:STRO)  TradingView Fri, 26 Jun 2026 20:37:17 GMT
 STRO Forecast — Price Target — Prediction for 2027  TradingView Fri, 26 Jun 2026 09:58:02 GMT
 sutro biopharma inc (stro) valuation: pe, pb & fair value analysis  TradingKey Tue, 23 Jun 2026 07:00:00 GMT
 sutro biopharma inc (stro) institutional confidence  TradingKey Thu, 18 Jun 2026 10:52:16 GMT
 sutro biopharma inc (stro) valuation: pe, pb & fair value analysis  TradingKey Thu, 18 Jun 2026 10:50:57 GMT
 sutro biopharma (stro) proxy filing summary  Quartr Tue, 09 Jun 2026 23:07:08 GMT
 [Form 4] SUTRO BIOPHARMA, INC. Insider Trading Activity  Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
 sutro biopharma (nasdaq: stro) reports 2026 annual meeting results  Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
 will sutro biopharma (nasdaq:stro) spend its cash wisely?  富途牛牛 Sat, 06 Jun 2026 14:54:01 GMT
 barclays initiates a buy rating on sutro biopharma (stro)  The Globe and Mail Fri, 29 May 2026 09:28:00 GMT
 stro initiated coverage by barclays -- rating set to overweight  GuruFocus Thu, 28 May 2026 17:53:14 GMT
 barclays initiates sutro biopharma at overweight with $56 price target  marketscreener.com Thu, 28 May 2026 11:38:27 GMT
 barclays initiates sutro biopharma stock with overweight rating  Investing.com Thu, 28 May 2026 07:00:00 GMT
 h.c. wainwright remains a buy on sutro biopharma (stro)  The Globe and Mail Wed, 27 May 2026 18:00:00 GMT
 bofa securities maintains sutro biopharma(stro.us) with sell rating  富途牛牛 Sat, 23 May 2026 13:10:06 GMT
 stro sec filings - sutro biopharma 10-k, 10-q, 8-k forms  Stock Titan Thu, 21 May 2026 19:45:20 GMT
 update: sutro biopharma shares rise after q1 loss narrows  Moomoo Sat, 16 May 2026 09:42:35 GMT
 stro upgraded by wedbush -- price target raised to $60  GuruFocus Sat, 16 May 2026 02:03:45 GMT
 stro maintained by leerink partners -- price target raised to $4  GuruFocus Fri, 15 May 2026 19:07:30 GMT
 stro upgraded by wedbush -- price target raised to $60  GuruFocus Fri, 15 May 2026 17:28:14 GMT
 kynam capital reports 5.27% stake in sutro biopharma (nasdaq: stro)  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 sutro biopharma shares rise after q1 loss narrows  marketscreener.com Fri, 15 May 2026 07:00:00 GMT
 update: sutro biopharma shares rise after q1 loss narrows  Moomoo Fri, 15 May 2026 07:00:00 GMT
 is sutro biopharma (stro) 189.6% overvalued after q1 2026? eps b  GuruFocus Fri, 15 May 2026 07:00:00 GMT
 wedbush upgrades sutro biopharma (stro)  MSN Fri, 15 May 2026 07:00:00 GMT
 sutro biopharma (stro) q1 revenue surpasses expectations  GuruFocus Fri, 15 May 2026 06:17:45 GMT
 sutro biopharma reports q1 eps ($2.94), consensus ($3.21)  TipRanks Thu, 14 May 2026 20:57:18 GMT
 [10-q] sutro biopharma, inc. quarterly earnings report  Stock Titan Thu, 14 May 2026 20:30:49 GMT
 sutro biopharma q1 loss narrows, revenue declines  marketscreener.com Thu, 14 May 2026 07:00:00 GMT
 sutro biopharma (stro) q1 revenue surpasses expectations  GuruFocus Thu, 14 May 2026 07:00:00 GMT
 affinity asset advisors (nasdaq: stro) discloses 6.5% stake  Stock Titan Thu, 14 May 2026 07:00:00 GMT
 sutro biopharma (stro) eps diluted (ttm)  Zacks Investment Research Fri, 08 May 2026 02:40:04 GMT
 sutro biopharma (stro) to release earnings on thursday  MarketBeat Thu, 07 May 2026 07:00:00 GMT
 citizens raises sutro biopharma price target to 41 dollars  HarianBasis.co Sat, 02 May 2026 09:31:13 GMT
 sutro biopharma (nasdaq:stro) upgraded at lifesci capital  MarketBeat Sat, 02 May 2026 07:00:00 GMT
 point72 group (nasdaq: stro) reports 5.7% stake — 946,829 shares  Stock Titan Fri, 01 May 2026 07:00:00 GMT
 sutro biopharma: recycling past data ahead of the readout, sell  Seeking Alpha Fri, 01 May 2026 03:22:26 GMT
 stro initiated coverage by mizuho -- rating set at outperform  GuruFocus Thu, 30 Apr 2026 10:58:03 GMT
 sutro biopharma initiated with an outperform at mizuho  TipRanks Thu, 30 Apr 2026 09:28:07 GMT
 Sutro Biopharma: Recycling Past Data Ahead Of The Readout, Sell  Seeking Alpha Thu, 30 Apr 2026 07:00:00 GMT
 mizuho initiates sutro biopharma stock coverage with outperform rating  Investing.com Thu, 30 Apr 2026 07:00:00 GMT
 mizuho initiates sutro biopharma at outperform with $50 price target  marketscreener.com Thu, 30 Apr 2026 07:00:00 GMT
 sutro biopharma (nasdaq:stro) hits new 1-year high - what's next?  MarketBeat Wed, 29 Apr 2026 18:21:54 GMT
 sutro biopharma strengthens financial position and advances adc pipeline  HarianBasis.co Wed, 29 Apr 2026 18:02:35 GMT
 5 tiny stocks that are on fire right now  Insider Monkey Wed, 29 Apr 2026 04:00:18 GMT
 sutro biopharma (nasdaq:stro) shares up 5.6% - what's next?  MarketBeat Tue, 28 Apr 2026 07:00:00 GMT
 sutro biopharma (nasdaq:stro) shares gap down - what's next?  MarketBeat Mon, 27 Apr 2026 07:00:00 GMT
 sutro biopharma prices $110m common stock offering  MSN Sun, 26 Apr 2026 23:27:40 GMT
 sutro biopharma (nasdaq:stro) shares down 6.1% - time to sell?  MarketBeat Fri, 24 Apr 2026 07:00:00 GMT
 sutro biopharma prices $110m common stock offering  MSN Thu, 23 Apr 2026 19:56:56 GMT
 stro maintains by citizens -- price target raised to $41.00  GuruFocus Thu, 23 Apr 2026 15:32:43 GMT
 citizens raises sutro biopharma stock price target on platform value  Investing.com Thu, 23 Apr 2026 07:00:00 GMT
 [ars] sutro biopharma, inc. sec filing  Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
 sutro biopharma, inc. $stro shares sold by jpmorgan chase & co.  MarketBeat Tue, 21 Apr 2026 07:00:00 GMT

Sutro Biopharma, Inc
(NASDAQ:STRO) 

STRO stock logo

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's prod...

Full Time Employees: 182
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends